ADMINISTRATION OF A COMBINED ORAL CONTRACEPTIVE CONTAINING ESTRADIOL VALERATE/DIENOGEST (E2V/DNG) BY WOMEN WITH MENORRHAGIA
article
OA: diamond
CC0
Abstract
Menorrhagia is the pathological condition which is negatively affecting physical, emotional and social quality life of the woman. Medicines of the choice of therapy of uterine bleedings are the combined oral contraceptives (COC). The estradiol valerate/ dienogest (E2V/DNG), represents the combined oral contraceptive (COC) recommended for women as contraceptive. Gives to feature of influence of medicine on endometrium the chance of its application in case of uterine bleedings. The hormones which are a part suppress excessive proliferation of endometrium that leads to reduction of amount of menstrual allocations. Results of a research which confirm successful application of E2V/DNG in case of the menorrhagia at the women of reproductive age in clinical situations who aren’t requiring operational treatment are provided.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (2)
References (6)
- Effect of a new oral contraceptive with estradiol valerate/dienogest on carbohydrate metabolism via openalex
- FIGO classification system (PALM‐COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age via openalex
- doi:10.1111/j.1471-0528.1990.tb16249.x via openalex
- doi:10.1016/j.ajog.2007.08.070 via openalex
- W2130690372 via openalex
- W2749570783 via openalex
Source provenance
- openalex
- last seen: 2026-05-10T10:52:06.415033+00:00
License: CC0
· commercial use OK